Cancer Immunology Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.9 | Q1 | 88.5% | 3.480 | Q1 | 98.2% |
| 2024 | 8.2 | Q1 | 90.8% | 3.630 | Q1 | 98.4% |
| 2023 | 8.1 | Q1 | 87.3% | 3.781 | Q1 | 98.6% |
| 2022 | 10.1 | Q1 | 86.9% | 3.552 | Q1 | 98.5% |
| 2021 | 12.0 | Q1 | 89.9% | 3.623 | Q1 | 98.6% |
| 2020 | — | — | 4.976 | Q1 | 99.0% | |
| 2019 | — | — | 4.598 | Q1 | 99.0% | |
| 2018 | — | — | 4.990 | Q1 | 98.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2326-6074
ISSN
2326-6066
country
UScoverage
2013-2026